(Q44327591)

English

Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFβ1-targeting peptides P17 and P144.

scientific article published on 12 November 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFβ1-targeting peptides P17 and P144. (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

neoplastic stem cells

1 reference

based on heuristic

inferred from title

liver metastasis

1 reference

based on heuristic

inferred from title

author name string

Idoia G Zubeldia

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Anne-Marie Bleau

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Miriam Redrado

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Diego Serrano

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Alice Agliano

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Carmen Gil-Puig

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Fernando Vidal-Vanaclocha

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Jon Lecanda

8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Alfonso Calvo

9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

12 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Experimental Cell Research

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

319

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

12-22

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Metastatic colorectal cancer: from improved survival to potential cure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

Transforming growth factor-beta signaling in cancer invasion and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor- Type I Receptor Kinase In vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

TGF-beta-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

Antimetastatic role of Smad4 signaling in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

The transforming growth factor-beta (TGF-β) mediates acquisition of a mesenchymal stem cell-like phenotype in human liver cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

Tumor-initiating stem cells in liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

Identification of peptide inhibitors of transforming growth factor beta 1 using a phage-displayed peptide library

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

Evaluation of bioluminescent imaging for noninvasive monitoring of colorectal cancer progression in the liver and its response to immunogene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

Ovarian metastasis from colorectal cancer: prognostic value of radical oophorectomy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

Circulating endothelial cells and progenitors: potential biomarkers of renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

Concise review: stem cell antigen-1: expression, function, and enigma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

Biological responses to TGF-β in the mammary epithelium show a complex dependency on Smad3 gene dosage with important implications for tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

Genes that mediate breast cancer metastasis to lung

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.004

7 January 2021

Identifiers

10.1016/J.YEXCR.2012.11.004

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44327591&oldid=2109468124"